Package 70518-3183-1

Brand: divalproex sodium

Generic: divalproex sodium
NDC Package

Package Facts

Identity

Package NDC 70518-3183-1
Digits Only 7051831831
Product NDC 70518-3183
Product ID 70518-3183_3a2505ad-023b-dc31-e063-6394a90a45dc
Description

100 POUCH in 1 BOX (70518-3183-1) / 1 TABLET, EXTENDED RELEASE in 1 POUCH (70518-3183-2)

Marketing

Marketing Status
Marketed Since 2023-07-30
Brand divalproex sodium
Generic divalproex sodium
Sample Package No

Linked Drug Pages (1)

Divalproex sodium ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "3a2505ad-023b-dc31-e063-6394a90a45dc", "openfda": {"unii": ["644VL95AO6"], "rxcui": ["1099563"], "spl_set_id": ["aa386ae3-ceac-4e3b-8fb1-ced3107a4c54"], "manufacturer_name": ["REMEDYREPACK INC."]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (70518-3183-0)", "package_ndc": "70518-3183-0", "marketing_start_date": "20210806"}, {"sample": false, "description": "100 POUCH in 1 BOX (70518-3183-1)  / 1 TABLET, EXTENDED RELEASE in 1 POUCH (70518-3183-2)", "package_ndc": "70518-3183-1", "marketing_start_date": "20230730"}], "brand_name": "Divalproex sodium", "product_id": "70518-3183_3a2505ad-023b-dc31-e063-6394a90a45dc", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Mood Stabilizer [EPC]"], "product_ndc": "70518-3183", "generic_name": "Divalproex sodium", "labeler_name": "REMEDYREPACK INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Divalproex sodium", "active_ingredients": [{"name": "DIVALPROEX SODIUM", "strength": "250 mg/1"}], "application_number": "ANDA209286", "marketing_category": "ANDA", "marketing_start_date": "20210806", "listing_expiration_date": "20261231"}